News & Blog

March 15, 2023 | In The News
ENDPOINT NEWS EXCLUSIVE: Sanofi, Astellas venture arms add cash to Avilar’s ‘ATAC’ mission
Read More
February 28, 2023 | Blog Post
Looking Ahead Series: Insights on Innovation from the MEC Council and the Brightest Minds
Read More
February 16, 2023 | Press Release
AVILAR THERAPEUTICS INCREASES FINANCING TO $75 MILLION TO ADVANCE PIPELINE OF NOVEL EXTRACELLULAR PROTEIN DEGRADERS
Read More
February 15, 2023 | Blog Post
Medical Excellence Foundation Announces First MERIT Grant
Read More
January 25, 2023 | In The News
Endpoints News: A stem cell pioneer sent an experiment into space. Patients are the next frontier
Read More
January 24, 2023 | Blog Post
Our Sophomore Year: A Review of 2022
Read More
January 05, 2023 | In The News
BioCentury: BioCentury’s 2022 class of emerging companies
Read More
January 05, 2023 | Blog Post
Looking Ahead Series: Developing Insights from the MEC Council and the Brightest Minds
Read More
January 04, 2023 | Press Release
Immunitas Therapeutics Announces First Patient Dosed in Phase 1/2a Study of IMT-009
Read More
December 21, 2022 | Press Release
Aspen Neuroscience Inks $40 Million Debt Deal with Silicon Valley Bank
Read More